Global Pharmacokinetics Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Pharmacokinetics Services market size was valued at USD 640.2 million in 2023 and is forecast to a readjusted size of USD 871.1 million by 2030 with a CAGR of 4.5% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pharmacokinetics Services industry chain, the market status of Small & Medium Enterprise (Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services), Large Enterprise (Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pharmacokinetics Services.
Regionally, the report analyzes the Pharmacokinetics Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmacokinetics Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pharmacokinetics Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmacokinetics Services industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmacokinetics Services market.
Regional Analysis: The report involves examining the Pharmacokinetics Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmacokinetics Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pharmacokinetics Services:
Company Analysis: Report covers individual Pharmacokinetics Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pharmacokinetics Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Small & Medium Enterprise, Large Enterprise).
Technology Analysis: Report covers specific technologies relevant to Pharmacokinetics Services. It assesses the current state, advancements, and potential future developments in Pharmacokinetics Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmacokinetics Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pharmacokinetics Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Pharmacokinetics Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmacokinetics Services, with revenue, gross margin and global market share of Pharmacokinetics Services from 2019 to 2024.
Chapter 3, the Pharmacokinetics Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharmacokinetics Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmacokinetics Services.
Chapter 13, to describe Pharmacokinetics Services research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pharmacokinetics Services industry chain, the market status of Small & Medium Enterprise (Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services), Large Enterprise (Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pharmacokinetics Services.
Regionally, the report analyzes the Pharmacokinetics Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmacokinetics Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pharmacokinetics Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmacokinetics Services industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmacokinetics Services market.
Regional Analysis: The report involves examining the Pharmacokinetics Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmacokinetics Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pharmacokinetics Services:
Company Analysis: Report covers individual Pharmacokinetics Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pharmacokinetics Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Small & Medium Enterprise, Large Enterprise).
Technology Analysis: Report covers specific technologies relevant to Pharmacokinetics Services. It assesses the current state, advancements, and potential future developments in Pharmacokinetics Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmacokinetics Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pharmacokinetics Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Small Molecules Pharmacokinetics Services
- Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
- Small & Medium Enterprise
- Large Enterprise
- Evotec AG (Germany)
- Pacific BioLabs (US)
- GVK Biosciences Private Limited (India)
- Shanghai Medicilon Inc. (China)
- Pharmaceutical Product Development, LLC (US)
- Charles River Laboratories International, Inc. (US)
- PAREXEL International Corporation (US)
- Eurofins Scientific, Inc. (Luxembourg)
- Frontage Labs (US)
- SGS SA (Switzerland)
- LGC Limited (UK)
- Creative Bioarray (US)
- Certara, L.P. (Germany)
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Pharmacokinetics Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmacokinetics Services, with revenue, gross margin and global market share of Pharmacokinetics Services from 2019 to 2024.
Chapter 3, the Pharmacokinetics Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharmacokinetics Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmacokinetics Services.
Chapter 13, to describe Pharmacokinetics Services research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Pharmacokinetics Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmacokinetics Services by Type
1.3.1 Overview: Global Pharmacokinetics Services Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Pharmacokinetics Services Consumption Value Market Share by Type in 2023
1.3.3 Small Molecules Pharmacokinetics Services
1.3.4 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
1.4 Global Pharmacokinetics Services Market by Application
1.4.1 Overview: Global Pharmacokinetics Services Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Small & Medium Enterprise
1.4.3 Large Enterprise
1.5 Global Pharmacokinetics Services Market Size & Forecast
1.6 Global Pharmacokinetics Services Market Size and Forecast by Region
1.6.1 Global Pharmacokinetics Services Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Pharmacokinetics Services Market Size by Region, (2019-2030)
1.6.3 North America Pharmacokinetics Services Market Size and Prospect (2019-2030)
1.6.4 Europe Pharmacokinetics Services Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Pharmacokinetics Services Market Size and Prospect (2019-2030)
1.6.6 South America Pharmacokinetics Services Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Pharmacokinetics Services Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Evotec AG (Germany)
2.1.1 Evotec AG (Germany) Details
2.1.2 Evotec AG (Germany) Major Business
2.1.3 Evotec AG (Germany) Pharmacokinetics Services Product and Solutions
2.1.4 Evotec AG (Germany) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Evotec AG (Germany) Recent Developments and Future Plans
2.2 Pacific BioLabs (US)
2.2.1 Pacific BioLabs (US) Details
2.2.2 Pacific BioLabs (US) Major Business
2.2.3 Pacific BioLabs (US) Pharmacokinetics Services Product and Solutions
2.2.4 Pacific BioLabs (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pacific BioLabs (US) Recent Developments and Future Plans
2.3 GVK Biosciences Private Limited (India)
2.3.1 GVK Biosciences Private Limited (India) Details
2.3.2 GVK Biosciences Private Limited (India) Major Business
2.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product and Solutions
2.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GVK Biosciences Private Limited (India) Recent Developments and Future Plans
2.4 Shanghai Medicilon Inc. (China)
2.4.1 Shanghai Medicilon Inc. (China) Details
2.4.2 Shanghai Medicilon Inc. (China) Major Business
2.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product and Solutions
2.4.4 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Shanghai Medicilon Inc. (China) Recent Developments and Future Plans
2.5 Pharmaceutical Product Development, LLC (US)
2.5.1 Pharmaceutical Product Development, LLC (US) Details
2.5.2 Pharmaceutical Product Development, LLC (US) Major Business
2.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product and Solutions
2.5.4 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pharmaceutical Product Development, LLC (US) Recent Developments and Future Plans
2.6 Charles River Laboratories International, Inc. (US)
2.6.1 Charles River Laboratories International, Inc. (US) Details
2.6.2 Charles River Laboratories International, Inc. (US) Major Business
2.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product and Solutions
2.6.4 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Charles River Laboratories International, Inc. (US) Recent Developments and Future Plans
2.7 PAREXEL International Corporation (US)
2.7.1 PAREXEL International Corporation (US) Details
2.7.2 PAREXEL International Corporation (US) Major Business
2.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Product and Solutions
2.7.4 PAREXEL International Corporation (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 PAREXEL International Corporation (US) Recent Developments and Future Plans
2.8 Eurofins Scientific, Inc. (Luxembourg)
2.8.1 Eurofins Scientific, Inc. (Luxembourg) Details
2.8.2 Eurofins Scientific, Inc. (Luxembourg) Major Business
2.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product and Solutions
2.8.4 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Developments and Future Plans
2.9 Frontage Labs (US)
2.9.1 Frontage Labs (US) Details
2.9.2 Frontage Labs (US) Major Business
2.9.3 Frontage Labs (US) Pharmacokinetics Services Product and Solutions
2.9.4 Frontage Labs (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Frontage Labs (US) Recent Developments and Future Plans
2.10 SGS SA (Switzerland)
2.10.1 SGS SA (Switzerland) Details
2.10.2 SGS SA (Switzerland) Major Business
2.10.3 SGS SA (Switzerland) Pharmacokinetics Services Product and Solutions
2.10.4 SGS SA (Switzerland) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 SGS SA (Switzerland) Recent Developments and Future Plans
2.11 LGC Limited (UK)
2.11.1 LGC Limited (UK) Details
2.11.2 LGC Limited (UK) Major Business
2.11.3 LGC Limited (UK) Pharmacokinetics Services Product and Solutions
2.11.4 LGC Limited (UK) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 LGC Limited (UK) Recent Developments and Future Plans
2.12 Creative Bioarray (US)
2.12.1 Creative Bioarray (US) Details
2.12.2 Creative Bioarray (US) Major Business
2.12.3 Creative Bioarray (US) Pharmacokinetics Services Product and Solutions
2.12.4 Creative Bioarray (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Creative Bioarray (US) Recent Developments and Future Plans
2.13 Certara, L.P. (Germany)
2.13.1 Certara, L.P. (Germany) Details
2.13.2 Certara, L.P. (Germany) Major Business
2.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Product and Solutions
2.13.4 Certara, L.P. (Germany) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Certara, L.P. (Germany) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmacokinetics Services Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Pharmacokinetics Services by Company Revenue
3.2.2 Top 3 Pharmacokinetics Services Players Market Share in 2023
3.2.3 Top 6 Pharmacokinetics Services Players Market Share in 2023
3.3 Pharmacokinetics Services Market: Overall Company Footprint Analysis
3.3.1 Pharmacokinetics Services Market: Region Footprint
3.3.2 Pharmacokinetics Services Market: Company Product Type Footprint
3.3.3 Pharmacokinetics Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmacokinetics Services Consumption Value and Market Share by Type (2019-2024)
4.2 Global Pharmacokinetics Services Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmacokinetics Services Consumption Value Market Share by Application (2019-2024)
5.2 Global Pharmacokinetics Services Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Pharmacokinetics Services Consumption Value by Type (2019-2030)
6.2 North America Pharmacokinetics Services Consumption Value by Application (2019-2030)
6.3 North America Pharmacokinetics Services Market Size by Country
6.3.1 North America Pharmacokinetics Services Consumption Value by Country (2019-2030)
6.3.2 United States Pharmacokinetics Services Market Size and Forecast (2019-2030)
6.3.3 Canada Pharmacokinetics Services Market Size and Forecast (2019-2030)
6.3.4 Mexico Pharmacokinetics Services Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Pharmacokinetics Services Consumption Value by Type (2019-2030)
7.2 Europe Pharmacokinetics Services Consumption Value by Application (2019-2030)
7.3 Europe Pharmacokinetics Services Market Size by Country
7.3.1 Europe Pharmacokinetics Services Consumption Value by Country (2019-2030)
7.3.2 Germany Pharmacokinetics Services Market Size and Forecast (2019-2030)
7.3.3 France Pharmacokinetics Services Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Pharmacokinetics Services Market Size and Forecast (2019-2030)
7.3.5 Russia Pharmacokinetics Services Market Size and Forecast (2019-2030)
7.3.6 Italy Pharmacokinetics Services Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Pharmacokinetics Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Pharmacokinetics Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Pharmacokinetics Services Market Size by Region
8.3.1 Asia-Pacific Pharmacokinetics Services Consumption Value by Region (2019-2030)
8.3.2 China Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.3 Japan Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.4 South Korea Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.5 India Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.7 Australia Pharmacokinetics Services Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Pharmacokinetics Services Consumption Value by Type (2019-2030)
9.2 South America Pharmacokinetics Services Consumption Value by Application (2019-2030)
9.3 South America Pharmacokinetics Services Market Size by Country
9.3.1 South America Pharmacokinetics Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Pharmacokinetics Services Market Size and Forecast (2019-2030)
9.3.3 Argentina Pharmacokinetics Services Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pharmacokinetics Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Pharmacokinetics Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Pharmacokinetics Services Market Size by Country
10.3.1 Middle East & Africa Pharmacokinetics Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Pharmacokinetics Services Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Pharmacokinetics Services Market Size and Forecast (2019-2030)
10.3.4 UAE Pharmacokinetics Services Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Pharmacokinetics Services Market Drivers
11.2 Pharmacokinetics Services Market Restraints
11.3 Pharmacokinetics Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Pharmacokinetics Services Industry Chain
12.2 Pharmacokinetics Services Upstream Analysis
12.3 Pharmacokinetics Services Midstream Analysis
12.4 Pharmacokinetics Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Pharmacokinetics Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmacokinetics Services by Type
1.3.1 Overview: Global Pharmacokinetics Services Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Pharmacokinetics Services Consumption Value Market Share by Type in 2023
1.3.3 Small Molecules Pharmacokinetics Services
1.3.4 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
1.4 Global Pharmacokinetics Services Market by Application
1.4.1 Overview: Global Pharmacokinetics Services Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Small & Medium Enterprise
1.4.3 Large Enterprise
1.5 Global Pharmacokinetics Services Market Size & Forecast
1.6 Global Pharmacokinetics Services Market Size and Forecast by Region
1.6.1 Global Pharmacokinetics Services Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Pharmacokinetics Services Market Size by Region, (2019-2030)
1.6.3 North America Pharmacokinetics Services Market Size and Prospect (2019-2030)
1.6.4 Europe Pharmacokinetics Services Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Pharmacokinetics Services Market Size and Prospect (2019-2030)
1.6.6 South America Pharmacokinetics Services Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Pharmacokinetics Services Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Evotec AG (Germany)
2.1.1 Evotec AG (Germany) Details
2.1.2 Evotec AG (Germany) Major Business
2.1.3 Evotec AG (Germany) Pharmacokinetics Services Product and Solutions
2.1.4 Evotec AG (Germany) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Evotec AG (Germany) Recent Developments and Future Plans
2.2 Pacific BioLabs (US)
2.2.1 Pacific BioLabs (US) Details
2.2.2 Pacific BioLabs (US) Major Business
2.2.3 Pacific BioLabs (US) Pharmacokinetics Services Product and Solutions
2.2.4 Pacific BioLabs (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pacific BioLabs (US) Recent Developments and Future Plans
2.3 GVK Biosciences Private Limited (India)
2.3.1 GVK Biosciences Private Limited (India) Details
2.3.2 GVK Biosciences Private Limited (India) Major Business
2.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product and Solutions
2.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GVK Biosciences Private Limited (India) Recent Developments and Future Plans
2.4 Shanghai Medicilon Inc. (China)
2.4.1 Shanghai Medicilon Inc. (China) Details
2.4.2 Shanghai Medicilon Inc. (China) Major Business
2.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product and Solutions
2.4.4 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Shanghai Medicilon Inc. (China) Recent Developments and Future Plans
2.5 Pharmaceutical Product Development, LLC (US)
2.5.1 Pharmaceutical Product Development, LLC (US) Details
2.5.2 Pharmaceutical Product Development, LLC (US) Major Business
2.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product and Solutions
2.5.4 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pharmaceutical Product Development, LLC (US) Recent Developments and Future Plans
2.6 Charles River Laboratories International, Inc. (US)
2.6.1 Charles River Laboratories International, Inc. (US) Details
2.6.2 Charles River Laboratories International, Inc. (US) Major Business
2.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product and Solutions
2.6.4 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Charles River Laboratories International, Inc. (US) Recent Developments and Future Plans
2.7 PAREXEL International Corporation (US)
2.7.1 PAREXEL International Corporation (US) Details
2.7.2 PAREXEL International Corporation (US) Major Business
2.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Product and Solutions
2.7.4 PAREXEL International Corporation (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 PAREXEL International Corporation (US) Recent Developments and Future Plans
2.8 Eurofins Scientific, Inc. (Luxembourg)
2.8.1 Eurofins Scientific, Inc. (Luxembourg) Details
2.8.2 Eurofins Scientific, Inc. (Luxembourg) Major Business
2.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product and Solutions
2.8.4 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Developments and Future Plans
2.9 Frontage Labs (US)
2.9.1 Frontage Labs (US) Details
2.9.2 Frontage Labs (US) Major Business
2.9.3 Frontage Labs (US) Pharmacokinetics Services Product and Solutions
2.9.4 Frontage Labs (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Frontage Labs (US) Recent Developments and Future Plans
2.10 SGS SA (Switzerland)
2.10.1 SGS SA (Switzerland) Details
2.10.2 SGS SA (Switzerland) Major Business
2.10.3 SGS SA (Switzerland) Pharmacokinetics Services Product and Solutions
2.10.4 SGS SA (Switzerland) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 SGS SA (Switzerland) Recent Developments and Future Plans
2.11 LGC Limited (UK)
2.11.1 LGC Limited (UK) Details
2.11.2 LGC Limited (UK) Major Business
2.11.3 LGC Limited (UK) Pharmacokinetics Services Product and Solutions
2.11.4 LGC Limited (UK) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 LGC Limited (UK) Recent Developments and Future Plans
2.12 Creative Bioarray (US)
2.12.1 Creative Bioarray (US) Details
2.12.2 Creative Bioarray (US) Major Business
2.12.3 Creative Bioarray (US) Pharmacokinetics Services Product and Solutions
2.12.4 Creative Bioarray (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Creative Bioarray (US) Recent Developments and Future Plans
2.13 Certara, L.P. (Germany)
2.13.1 Certara, L.P. (Germany) Details
2.13.2 Certara, L.P. (Germany) Major Business
2.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Product and Solutions
2.13.4 Certara, L.P. (Germany) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Certara, L.P. (Germany) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmacokinetics Services Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Pharmacokinetics Services by Company Revenue
3.2.2 Top 3 Pharmacokinetics Services Players Market Share in 2023
3.2.3 Top 6 Pharmacokinetics Services Players Market Share in 2023
3.3 Pharmacokinetics Services Market: Overall Company Footprint Analysis
3.3.1 Pharmacokinetics Services Market: Region Footprint
3.3.2 Pharmacokinetics Services Market: Company Product Type Footprint
3.3.3 Pharmacokinetics Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmacokinetics Services Consumption Value and Market Share by Type (2019-2024)
4.2 Global Pharmacokinetics Services Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmacokinetics Services Consumption Value Market Share by Application (2019-2024)
5.2 Global Pharmacokinetics Services Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Pharmacokinetics Services Consumption Value by Type (2019-2030)
6.2 North America Pharmacokinetics Services Consumption Value by Application (2019-2030)
6.3 North America Pharmacokinetics Services Market Size by Country
6.3.1 North America Pharmacokinetics Services Consumption Value by Country (2019-2030)
6.3.2 United States Pharmacokinetics Services Market Size and Forecast (2019-2030)
6.3.3 Canada Pharmacokinetics Services Market Size and Forecast (2019-2030)
6.3.4 Mexico Pharmacokinetics Services Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Pharmacokinetics Services Consumption Value by Type (2019-2030)
7.2 Europe Pharmacokinetics Services Consumption Value by Application (2019-2030)
7.3 Europe Pharmacokinetics Services Market Size by Country
7.3.1 Europe Pharmacokinetics Services Consumption Value by Country (2019-2030)
7.3.2 Germany Pharmacokinetics Services Market Size and Forecast (2019-2030)
7.3.3 France Pharmacokinetics Services Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Pharmacokinetics Services Market Size and Forecast (2019-2030)
7.3.5 Russia Pharmacokinetics Services Market Size and Forecast (2019-2030)
7.3.6 Italy Pharmacokinetics Services Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Pharmacokinetics Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Pharmacokinetics Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Pharmacokinetics Services Market Size by Region
8.3.1 Asia-Pacific Pharmacokinetics Services Consumption Value by Region (2019-2030)
8.3.2 China Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.3 Japan Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.4 South Korea Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.5 India Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Pharmacokinetics Services Market Size and Forecast (2019-2030)
8.3.7 Australia Pharmacokinetics Services Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Pharmacokinetics Services Consumption Value by Type (2019-2030)
9.2 South America Pharmacokinetics Services Consumption Value by Application (2019-2030)
9.3 South America Pharmacokinetics Services Market Size by Country
9.3.1 South America Pharmacokinetics Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Pharmacokinetics Services Market Size and Forecast (2019-2030)
9.3.3 Argentina Pharmacokinetics Services Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pharmacokinetics Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Pharmacokinetics Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Pharmacokinetics Services Market Size by Country
10.3.1 Middle East & Africa Pharmacokinetics Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Pharmacokinetics Services Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Pharmacokinetics Services Market Size and Forecast (2019-2030)
10.3.4 UAE Pharmacokinetics Services Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Pharmacokinetics Services Market Drivers
11.2 Pharmacokinetics Services Market Restraints
11.3 Pharmacokinetics Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Pharmacokinetics Services Industry Chain
12.2 Pharmacokinetics Services Upstream Analysis
12.3 Pharmacokinetics Services Midstream Analysis
12.4 Pharmacokinetics Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Pharmacokinetics Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pharmacokinetics Services Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Pharmacokinetics Services Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Pharmacokinetics Services Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Evotec AG (Germany) Company Information, Head Office, and Major Competitors
Table 6. Evotec AG (Germany) Major Business
Table 7. Evotec AG (Germany) Pharmacokinetics Services Product and Solutions
Table 8. Evotec AG (Germany) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Evotec AG (Germany) Recent Developments and Future Plans
Table 10. Pacific BioLabs (US) Company Information, Head Office, and Major Competitors
Table 11. Pacific BioLabs (US) Major Business
Table 12. Pacific BioLabs (US) Pharmacokinetics Services Product and Solutions
Table 13. Pacific BioLabs (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pacific BioLabs (US) Recent Developments and Future Plans
Table 15. GVK Biosciences Private Limited (India) Company Information, Head Office, and Major Competitors
Table 16. GVK Biosciences Private Limited (India) Major Business
Table 17. GVK Biosciences Private Limited (India) Pharmacokinetics Services Product and Solutions
Table 18. GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GVK Biosciences Private Limited (India) Recent Developments and Future Plans
Table 20. Shanghai Medicilon Inc. (China) Company Information, Head Office, and Major Competitors
Table 21. Shanghai Medicilon Inc. (China) Major Business
Table 22. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product and Solutions
Table 23. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Shanghai Medicilon Inc. (China) Recent Developments and Future Plans
Table 25. Pharmaceutical Product Development, LLC (US) Company Information, Head Office, and Major Competitors
Table 26. Pharmaceutical Product Development, LLC (US) Major Business
Table 27. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product and Solutions
Table 28. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Pharmaceutical Product Development, LLC (US) Recent Developments and Future Plans
Table 30. Charles River Laboratories International, Inc. (US) Company Information, Head Office, and Major Competitors
Table 31. Charles River Laboratories International, Inc. (US) Major Business
Table 32. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product and Solutions
Table 33. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Charles River Laboratories International, Inc. (US) Recent Developments and Future Plans
Table 35. PAREXEL International Corporation (US) Company Information, Head Office, and Major Competitors
Table 36. PAREXEL International Corporation (US) Major Business
Table 37. PAREXEL International Corporation (US) Pharmacokinetics Services Product and Solutions
Table 38. PAREXEL International Corporation (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. PAREXEL International Corporation (US) Recent Developments and Future Plans
Table 40. Eurofins Scientific, Inc. (Luxembourg) Company Information, Head Office, and Major Competitors
Table 41. Eurofins Scientific, Inc. (Luxembourg) Major Business
Table 42. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product and Solutions
Table 43. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Eurofins Scientific, Inc. (Luxembourg) Recent Developments and Future Plans
Table 45. Frontage Labs (US) Company Information, Head Office, and Major Competitors
Table 46. Frontage Labs (US) Major Business
Table 47. Frontage Labs (US) Pharmacokinetics Services Product and Solutions
Table 48. Frontage Labs (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Frontage Labs (US) Recent Developments and Future Plans
Table 50. SGS SA (Switzerland) Company Information, Head Office, and Major Competitors
Table 51. SGS SA (Switzerland) Major Business
Table 52. SGS SA (Switzerland) Pharmacokinetics Services Product and Solutions
Table 53. SGS SA (Switzerland) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. SGS SA (Switzerland) Recent Developments and Future Plans
Table 55. LGC Limited (UK) Company Information, Head Office, and Major Competitors
Table 56. LGC Limited (UK) Major Business
Table 57. LGC Limited (UK) Pharmacokinetics Services Product and Solutions
Table 58. LGC Limited (UK) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. LGC Limited (UK) Recent Developments and Future Plans
Table 60. Creative Bioarray (US) Company Information, Head Office, and Major Competitors
Table 61. Creative Bioarray (US) Major Business
Table 62. Creative Bioarray (US) Pharmacokinetics Services Product and Solutions
Table 63. Creative Bioarray (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Creative Bioarray (US) Recent Developments and Future Plans
Table 65. Certara, L.P. (Germany) Company Information, Head Office, and Major Competitors
Table 66. Certara, L.P. (Germany) Major Business
Table 67. Certara, L.P. (Germany) Pharmacokinetics Services Product and Solutions
Table 68. Certara, L.P. (Germany) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Certara, L.P. (Germany) Recent Developments and Future Plans
Table 70. Global Pharmacokinetics Services Revenue (USD Million) by Players (2019-2024)
Table 71. Global Pharmacokinetics Services Revenue Share by Players (2019-2024)
Table 72. Breakdown of Pharmacokinetics Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Pharmacokinetics Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Pharmacokinetics Services Players
Table 75. Pharmacokinetics Services Market: Company Product Type Footprint
Table 76. Pharmacokinetics Services Market: Company Product Application Footprint
Table 77. Pharmacokinetics Services New Market Entrants and Barriers to Market Entry
Table 78. Pharmacokinetics Services Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Pharmacokinetics Services Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Pharmacokinetics Services Consumption Value Share by Type (2019-2024)
Table 81. Global Pharmacokinetics Services Consumption Value Forecast by Type (2025-2030)
Table 82. Global Pharmacokinetics Services Consumption Value by Application (2019-2024)
Table 83. Global Pharmacokinetics Services Consumption Value Forecast by Application (2025-2030)
Table 84. North America Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Pharmacokinetics Services Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Pharmacokinetics Services Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Pharmacokinetics Services Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Pharmacokinetics Services Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Pharmacokinetics Services Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Pharmacokinetics Services Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Pharmacokinetics Services Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Pharmacokinetics Services Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Pharmacokinetics Services Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Pharmacokinetics Services Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Pharmacokinetics Services Raw Material
Table 115. Key Suppliers of Pharmacokinetics Services Raw Materials
Table 1. Global Pharmacokinetics Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pharmacokinetics Services Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Pharmacokinetics Services Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Pharmacokinetics Services Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Evotec AG (Germany) Company Information, Head Office, and Major Competitors
Table 6. Evotec AG (Germany) Major Business
Table 7. Evotec AG (Germany) Pharmacokinetics Services Product and Solutions
Table 8. Evotec AG (Germany) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Evotec AG (Germany) Recent Developments and Future Plans
Table 10. Pacific BioLabs (US) Company Information, Head Office, and Major Competitors
Table 11. Pacific BioLabs (US) Major Business
Table 12. Pacific BioLabs (US) Pharmacokinetics Services Product and Solutions
Table 13. Pacific BioLabs (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pacific BioLabs (US) Recent Developments and Future Plans
Table 15. GVK Biosciences Private Limited (India) Company Information, Head Office, and Major Competitors
Table 16. GVK Biosciences Private Limited (India) Major Business
Table 17. GVK Biosciences Private Limited (India) Pharmacokinetics Services Product and Solutions
Table 18. GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GVK Biosciences Private Limited (India) Recent Developments and Future Plans
Table 20. Shanghai Medicilon Inc. (China) Company Information, Head Office, and Major Competitors
Table 21. Shanghai Medicilon Inc. (China) Major Business
Table 22. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product and Solutions
Table 23. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Shanghai Medicilon Inc. (China) Recent Developments and Future Plans
Table 25. Pharmaceutical Product Development, LLC (US) Company Information, Head Office, and Major Competitors
Table 26. Pharmaceutical Product Development, LLC (US) Major Business
Table 27. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product and Solutions
Table 28. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Pharmaceutical Product Development, LLC (US) Recent Developments and Future Plans
Table 30. Charles River Laboratories International, Inc. (US) Company Information, Head Office, and Major Competitors
Table 31. Charles River Laboratories International, Inc. (US) Major Business
Table 32. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product and Solutions
Table 33. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Charles River Laboratories International, Inc. (US) Recent Developments and Future Plans
Table 35. PAREXEL International Corporation (US) Company Information, Head Office, and Major Competitors
Table 36. PAREXEL International Corporation (US) Major Business
Table 37. PAREXEL International Corporation (US) Pharmacokinetics Services Product and Solutions
Table 38. PAREXEL International Corporation (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. PAREXEL International Corporation (US) Recent Developments and Future Plans
Table 40. Eurofins Scientific, Inc. (Luxembourg) Company Information, Head Office, and Major Competitors
Table 41. Eurofins Scientific, Inc. (Luxembourg) Major Business
Table 42. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product and Solutions
Table 43. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Eurofins Scientific, Inc. (Luxembourg) Recent Developments and Future Plans
Table 45. Frontage Labs (US) Company Information, Head Office, and Major Competitors
Table 46. Frontage Labs (US) Major Business
Table 47. Frontage Labs (US) Pharmacokinetics Services Product and Solutions
Table 48. Frontage Labs (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Frontage Labs (US) Recent Developments and Future Plans
Table 50. SGS SA (Switzerland) Company Information, Head Office, and Major Competitors
Table 51. SGS SA (Switzerland) Major Business
Table 52. SGS SA (Switzerland) Pharmacokinetics Services Product and Solutions
Table 53. SGS SA (Switzerland) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. SGS SA (Switzerland) Recent Developments and Future Plans
Table 55. LGC Limited (UK) Company Information, Head Office, and Major Competitors
Table 56. LGC Limited (UK) Major Business
Table 57. LGC Limited (UK) Pharmacokinetics Services Product and Solutions
Table 58. LGC Limited (UK) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. LGC Limited (UK) Recent Developments and Future Plans
Table 60. Creative Bioarray (US) Company Information, Head Office, and Major Competitors
Table 61. Creative Bioarray (US) Major Business
Table 62. Creative Bioarray (US) Pharmacokinetics Services Product and Solutions
Table 63. Creative Bioarray (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Creative Bioarray (US) Recent Developments and Future Plans
Table 65. Certara, L.P. (Germany) Company Information, Head Office, and Major Competitors
Table 66. Certara, L.P. (Germany) Major Business
Table 67. Certara, L.P. (Germany) Pharmacokinetics Services Product and Solutions
Table 68. Certara, L.P. (Germany) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Certara, L.P. (Germany) Recent Developments and Future Plans
Table 70. Global Pharmacokinetics Services Revenue (USD Million) by Players (2019-2024)
Table 71. Global Pharmacokinetics Services Revenue Share by Players (2019-2024)
Table 72. Breakdown of Pharmacokinetics Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Pharmacokinetics Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Pharmacokinetics Services Players
Table 75. Pharmacokinetics Services Market: Company Product Type Footprint
Table 76. Pharmacokinetics Services Market: Company Product Application Footprint
Table 77. Pharmacokinetics Services New Market Entrants and Barriers to Market Entry
Table 78. Pharmacokinetics Services Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Pharmacokinetics Services Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Pharmacokinetics Services Consumption Value Share by Type (2019-2024)
Table 81. Global Pharmacokinetics Services Consumption Value Forecast by Type (2025-2030)
Table 82. Global Pharmacokinetics Services Consumption Value by Application (2019-2024)
Table 83. Global Pharmacokinetics Services Consumption Value Forecast by Application (2025-2030)
Table 84. North America Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Pharmacokinetics Services Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Pharmacokinetics Services Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Pharmacokinetics Services Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Pharmacokinetics Services Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Pharmacokinetics Services Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Pharmacokinetics Services Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Pharmacokinetics Services Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Pharmacokinetics Services Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Pharmacokinetics Services Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Pharmacokinetics Services Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Pharmacokinetics Services Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Pharmacokinetics Services Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Pharmacokinetics Services Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Pharmacokinetics Services Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Pharmacokinetics Services Raw Material
Table 115. Key Suppliers of Pharmacokinetics Services Raw Materials
LIST OF FIGURES
Figure 1. Pharmacokinetics Services Picture
Figure 2. Global Pharmacokinetics Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pharmacokinetics Services Consumption Value Market Share by Type in 2023
Figure 4. Small Molecules Pharmacokinetics Services
Figure 5. Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Figure 6. Global Pharmacokinetics Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Pharmacokinetics Services Consumption Value Market Share by Application in 2023
Figure 8. Small & Medium Enterprise Picture
Figure 9. Large Enterprise Picture
Figure 10. Global Pharmacokinetics Services Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Pharmacokinetics Services Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Pharmacokinetics Services Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Pharmacokinetics Services Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Pharmacokinetics Services Consumption Value Market Share by Region in 2023
Figure 15. North America Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Pharmacokinetics Services Revenue Share by Players in 2023
Figure 21. Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Pharmacokinetics Services Market Share in 2023
Figure 23. Global Top 6 Players Pharmacokinetics Services Market Share in 2023
Figure 24. Global Pharmacokinetics Services Consumption Value Share by Type (2019-2024)
Figure 25. Global Pharmacokinetics Services Market Share Forecast by Type (2025-2030)
Figure 26. Global Pharmacokinetics Services Consumption Value Share by Application (2019-2024)
Figure 27. Global Pharmacokinetics Services Market Share Forecast by Application (2025-2030)
Figure 28. North America Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Pharmacokinetics Services Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Pharmacokinetics Services Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 38. France Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Pharmacokinetics Services Consumption Value Market Share by Region (2019-2030)
Figure 45. China Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 48. India Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Pharmacokinetics Services Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Pharmacokinetics Services Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 62. Pharmacokinetics Services Market Drivers
Figure 63. Pharmacokinetics Services Market Restraints
Figure 64. Pharmacokinetics Services Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Pharmacokinetics Services in 2023
Figure 67. Manufacturing Process Analysis of Pharmacokinetics Services
Figure 68. Pharmacokinetics Services Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Pharmacokinetics Services Picture
Figure 2. Global Pharmacokinetics Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pharmacokinetics Services Consumption Value Market Share by Type in 2023
Figure 4. Small Molecules Pharmacokinetics Services
Figure 5. Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Figure 6. Global Pharmacokinetics Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Pharmacokinetics Services Consumption Value Market Share by Application in 2023
Figure 8. Small & Medium Enterprise Picture
Figure 9. Large Enterprise Picture
Figure 10. Global Pharmacokinetics Services Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Pharmacokinetics Services Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Pharmacokinetics Services Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Pharmacokinetics Services Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Pharmacokinetics Services Consumption Value Market Share by Region in 2023
Figure 15. North America Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Pharmacokinetics Services Revenue Share by Players in 2023
Figure 21. Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Pharmacokinetics Services Market Share in 2023
Figure 23. Global Top 6 Players Pharmacokinetics Services Market Share in 2023
Figure 24. Global Pharmacokinetics Services Consumption Value Share by Type (2019-2024)
Figure 25. Global Pharmacokinetics Services Market Share Forecast by Type (2025-2030)
Figure 26. Global Pharmacokinetics Services Consumption Value Share by Application (2019-2024)
Figure 27. Global Pharmacokinetics Services Market Share Forecast by Application (2025-2030)
Figure 28. North America Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Pharmacokinetics Services Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Pharmacokinetics Services Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 38. France Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Pharmacokinetics Services Consumption Value Market Share by Region (2019-2030)
Figure 45. China Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 48. India Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Pharmacokinetics Services Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Pharmacokinetics Services Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Pharmacokinetics Services Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Pharmacokinetics Services Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Pharmacokinetics Services Consumption Value (2019-2030) & (USD Million)
Figure 62. Pharmacokinetics Services Market Drivers
Figure 63. Pharmacokinetics Services Market Restraints
Figure 64. Pharmacokinetics Services Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Pharmacokinetics Services in 2023
Figure 67. Manufacturing Process Analysis of Pharmacokinetics Services
Figure 68. Pharmacokinetics Services Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
